Otofonix Encore vs RxEars Rxi

The Otofonix Encore is a budget-priced prescription hearing aid available for $295, earning a C grade with a SoundScore of 2.7/5 in our lab testing. This behind-the-ear device ranks #37 of 39 in the Prescription Hearing Aid category, placing it in the bottom tier of its class. In our standardized testing, the Encore demonstrates one clear strength: excellent feedback handling at 4.7/5, which means users are unlikely to experience whistling or squealing during normal use. However, the device shows significant limitations in other areas. Speech intelligibility scores are low in both quiet (1.0/5) and noisy environments (1.0/5), falling 2.40 and 1.11 points below category averages respectively. Music streaming performance scored 0.0/5, indicating this device is not suitable for those who want to stream audio content. The Encore uses disposable batteries and comes in a traditional behind-the-ear style. Notably, our tuned fit testing showed a slight decrease in overall performance compared to the initial fit, with the normalized score dropping from 2.8/5 to 2.4/5. Own-voice comfort also declined substantially when moving to a more occluding coupling. At this price point, consumers may want to consider alternatives. The RxEars Rxi offers substantially better performance at a similar budget price point with a score of 4.07/5. The Otofonix Encore may appeal to buyers seeking a very low-cost entry into prescription hearing aids who prioritize feedback stability, but those needing reliable speech clarity or streaming capabilities should explore other options.

The RxEars Rxi is a budget-priced prescription hearing aid in an invisible-in-ear style, earning an A grade with a SoundScore of 4.1/5 in our lab testing. At $499, it ranks #24 of 39 prescription hearing aids tested, placing it in the top 59% of its category. This device demonstrates notable strengths in speech understanding in quiet environments, scoring 4.3/5—a strong result that sits 0.89 points above the category average of 3.40/5. Feedback handling is excellent at 4.7/5, providing stable performance during movement without the whistling that can plague some hearing aids. Speech in noise performance is mixed at 2.1/5, essentially matching the category average. The RxEars Rxi has significant limitations to consider. Own-voice comfort scores low at 1.6/5, falling 1.10 points below the category average—users may notice their own voice sounds unnatural or boomy. Music streaming is not supported, scoring 0.0/5, which is 2.76 points below the category average. This device uses disposable batteries rather than rechargeables. The RxEars Rxi is best suited for users who prioritize discreet cosmetics and clear speech understanding in quieter settings, and who don't need music streaming capabilities. Those sensitive to own-voice quality or who frequently listen to streamed audio should explore alternatives.